Evidence map›Paper›PMID 42743357›Full record

ArticlePLoS pathogens2026

Genomic epidemiology of coxsackievirus A24 variant during the 2024 acute hemorrhagic conjunctivitis outbreak in Coastal Kenya.

John Mwita Morobe, Edidah M Ong'era, Arnold W Lambisia, Samuel O Odoyo, Martin Mutunga, Esther N Katama, Robinson Cheruiyot, Joyce U Nyiro, Everlyn Kamau, Charlotte J Houldcroft and 4 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

John Mwita MorobeKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.ORCID https://orcid.org/0000-0003-2398-6717
Edidah M Ong'eraKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Arnold W LambisiaKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Samuel O OdoyoKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Martin MutungaKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Esther N KatamaKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Robinson CheruiyotKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Joyce U NyiroKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Everlyn KamauUniversity of California, San Francisco, United States of America.
Charlotte J HouldcroftDepartment of Genetics, University of Cambridge, Cambridge, United Kingdom.
Matt KeelingThe Zeeman Institute for Systems Biology and Infectious Disease Epidemiology, Research (SBIDER), University of Warwick, Coventry, United Kingdom.
Katherine GallagherKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Edward C HolmesSchool of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia.
Charles N AgotiKenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Several African countries experienced a surge in acute hemorrhagic conjunctivitis (AHC) cases in 2024. Investigations in Kenya, Mayotte (an Indian Ocean island) and Tanzania identified coxsackievirus A24 variant (CVA24v) as the causative agent. To date, however, limited genomic data exist to elucidate the sources, epidemiology, and evolution of CVA24v in Africa. We generated 245 CVA24v genomes from samples collected between January and September 2024 in coastal Kenya, representing the largest outbreak CVA24v genomic data set available globally. Phylogenetic analysis showed that these viruses belonged to genotype IV, falling into two major clusters that differed by 52 nucleotide and five amino acid changes, and with an intra-species recombination event involving another enterovirus in the 3Dpol gene. Notably, the Kenyan sequences clustered closely with contemporaneous Africa (2024) sequences, specifically Mayotte and Malawi, reflecting a regionally connected CVA24v outbreak, but were distinct from those sampled previously in Asia in 2023, with phylodynamic analysis revealing that the Most Recent Common Ancestor of Kenyan sequences existed between June and October 2023. In summary, this study provides the first detailed genomic analysis of CVA24v from Africa to inform future surveillance and control strategies.

Indexed as

Conjunctivitis, Acute HemorrhagicCoxsackievirus InfectionsDisease OutbreaksEnterovirus C, HumanGenome, ViralGenotypeHumansKenyaPhylogeny

Identifiers

PMID42743357
PMCPMC13592715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.